These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9344329

  • 1. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus.
    Kovacs B, Liossis SN, Dennis GJ, Tsokos GC.
    Autoimmunity; 1997; 25(4):213-21. PubMed ID: 9344329
    [Abstract] [Full Text] [Related]

  • 2. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 3. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha.
    Kovacs B, Vassilopoulos D, Vogelgesang SA, Tsokos GC.
    Clin Immunol Immunopathol; 1996 Dec; 81(3):293-302. PubMed ID: 8938108
    [Abstract] [Full Text] [Related]

  • 4. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 5. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O.
    Cell Immunol; 1997 Oct 10; 181(1):93-100. PubMed ID: 9344501
    [Abstract] [Full Text] [Related]

  • 6. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
    Song LJ, Wang X, Wang XP, Li D, Ding F, Liu HX, Yu X, Li XF, Shu Q.
    Diagn Pathol; 2015 Jun 16; 10():71. PubMed ID: 26076826
    [Abstract] [Full Text] [Related]

  • 7. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
    Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR.
    Arthritis Rheum; 1997 Feb 16; 40(2):306-17. PubMed ID: 9041943
    [Abstract] [Full Text] [Related]

  • 8. [Role of Fas-FasL and caspase-3 signal transduction pathway in promoting apoptosis of T lymphocyte subset in SLE patients].
    Chen X, Wang LL, Cai B, Chen J, Feng WH.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep 16; 22(5):588-90. PubMed ID: 16948902
    [Abstract] [Full Text] [Related]

  • 9. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells.
    Kaplan MJ, Lewis EE, Shelden EA, Somers E, Pavlic R, McCune WJ, Richardson BC.
    J Immunol; 2002 Nov 15; 169(10):6020-9. PubMed ID: 12421989
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T.
    Arthritis Rheum; 1998 Feb 15; 41(2):344-53. PubMed ID: 9485093
    [Abstract] [Full Text] [Related]

  • 11. Fas ligand expression and function in systemic lupus erythematosus.
    McNally J, Yoo DH, Drappa J, Chu JL, Yagita H, Friedman SM, Elkon KB.
    J Immunol; 1997 Nov 01; 159(9):4628-36. PubMed ID: 9379065
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.
    Georgescu L, Vakkalanka RK, Elkon KB, Crow MK.
    J Clin Invest; 1997 Nov 15; 100(10):2622-33. PubMed ID: 9366578
    [Abstract] [Full Text] [Related]

  • 13. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
    Li B, Bassiri H, Rossman MD, Kramer P, Eyuboglu AF, Torres M, Sada E, Imir T, Carding SR.
    J Immunol; 1998 Aug 01; 161(3):1558-67. PubMed ID: 9686624
    [Abstract] [Full Text] [Related]

  • 14. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct 01; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 15. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis.
    Zhang J, Bárdos T, Mikecz K, Finnegan A, Glant TT.
    J Immunol; 2001 Apr 15; 166(8):4981-6. PubMed ID: 11290777
    [Abstract] [Full Text] [Related]

  • 16. Lck is required for activation-induced T cell death after TCR ligation with partial agonists.
    Yu XZ, Levin SD, Madrenas J, Anasetti C.
    J Immunol; 2004 Feb 01; 172(3):1437-43. PubMed ID: 14734719
    [Abstract] [Full Text] [Related]

  • 17. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y.
    Hokkaido Igaku Zasshi; 1997 Jul 01; 72(4):443-55. PubMed ID: 9266252
    [Abstract] [Full Text] [Related]

  • 18. CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus.
    Tao D, Shangwu L, Qun W, Yan L, Wei J, Junyan L, Feili G, Boquan J, Jinquan T.
    J Immunol; 2005 Feb 01; 174(3):1281-90. PubMed ID: 15661884
    [Abstract] [Full Text] [Related]

  • 19. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S, Krause SW, Halbritter D, Zhang HG, Mountz JD, Schölmerich J, Fleck M.
    J Immunol; 2003 Jun 01; 170(11):5406-13. PubMed ID: 12759415
    [Abstract] [Full Text] [Related]

  • 20. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia.
    Amasaki Y, Kobayashi S, Takeda T, Ogura N, Jodo S, Nakabayashi T, Tsutsumi A, Fujisaku A, Koike T.
    Clin Exp Immunol; 1995 Feb 01; 99(2):245-50. PubMed ID: 7531628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.